Displaying 201 - 210 of 620
Addressing the global Pegasys® shortage
Updated:
Following Health Canada’s decision to grant ropeginterferon (BESREMi®) exceptional importation status, some of the provinces and private insurance plans have been starting to cover BESREMi® treatment. Work is continuing in the provinces where there is not yet coverage.
Advocacy, Partners, Myeloproliferative neoplasms
Image
Problems sleeping during and after treatment
Updated:
Cancer treatments can disrupt sleep. Find out how treatments can affect sleep and what strategies you can use to sleep better.
Treatment and side effects
Lori Galbraith: First Connection Volunteer of the Year 2024
Updated:
As we do every year at this time, we highlight one English-speaking volunteer (and one French-speaking volunteer) for outstanding contributions to our First Connection peer support programs.
Events, Stories, Volunteers, Leukemia
I have a blood cancer
Updated:
Get the support you need. Access one-on-one personalized support. Support groups. First connection peer support program.
I am a blood cancer survivor
Updated:
Get the support you need. Access one-on-one personalized support, Support groups, and First connection peer support program.
Monthly Donations
Updated:
The needs of a person facing a blood cancer are complex, and can be overwhelming. But how you choose to give can be a game changer.
LLSC & CANO formalize and extend collaboration
Updated:
To further extend their collaboration, raise awareness on blood cancers, and to formalize their commitment to their partnership, the CANO and The Leukemia & Lymphoma Society of Canada (LLSC) have signed a memorandum of understanding (MOU) represented by Pascale Rousseau,…
Events, Partners
Image
Immune effector cell-associated neurotoxicity syndrome (ICANS)
Updated:
Immune effector cell-associated neurotoxicity syndrome (ICANS) is a side effect that can happen after some forms of immunotherapy treatment. It may cause you to experience serious neurological symptoms.
Treatment and side effects
Image
Myelofibrosis (MF) therapies: From palliation to disease modification - myeloproliferative neoplasms (MPN) conference 2025
Updated:
Dr. Vikas Gupta, Hematologist at the Princess Margaret Cancer Centre in Toronto, reviewed Myelofibrosis (MF) and the evolution in diagnosis, treatment options and aspects of follow-up care in this 1-hour webcast as part of MPN Conference 2025.
Myeloproliferative neoplasms
Polycythemia Vera (PV)
Updated:
Learn more about polycythemia vera (PV) and the resources we have available.
Myeloproliferative neoplasms